Kymera Therapeutics Inc Sustainability Reports
Kymera Therapeutics, Inc. is a clinical-stage biotechnology company focused on inventing and developing targeted protein degradation therapies. The company utilizes its proprietary Pegasus platform to target and eliminate disease-causing proteins for autoimmune, inflammatory, and oncology conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00SDHC8F9
3 reports from 2021 to 2024
Company Profile
Kymera Therapeutics, Inc. is a clinical-stage biotechnology company focused on inventing and developing targeted protein degradation therapies. The company utilizes its proprietary Pegasus platform to target and eliminate disease-causing proteins for autoimmune, inflammatory, and oncology conditions.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
